Bank Of Montreal Staar Surgical CO Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Staar Surgical CO stock. As of the latest transaction made, Bank Of Montreal holds 6,728 shares of STAA stock, worth $211,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,728

Previous 6,476 3.89%

Holding current value

$211,662

Previous $247,000 29.55%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.07 - $52.25 $9,593 - $13,167	252 Added 3.89%	6,728 $320,000
Q1 2024 May 13, 2024	BUY	$27.67 - $39.61 $179,190 - $256,514	6,476 New	6,476 $247,000
Q3 2023 Nov 01, 2023	BUY	$39.39 - $58.12 $81,104 - $119,669	2,059 Added 35.6%	7,842 $315,000
Q2 2023 Aug 02, 2023	SELL	$50.45 - $72.82 $20,987 - $30,293	-416 Reduced 6.71%	5,783 $304,000
Q1 2023 Jun 13, 2024	BUY	$51.25 - $79.34 $94,915 - $146,937	1,852 Added 28.6%	8,328 $532,000
Q4 2022 Feb 01, 2023	SELL	$46.82 - $76.2 $198,189 - $322,554	-4,233 Reduced 40.58%	6,199 $300,000
Q3 2022 Nov 10, 2022	SELL	$70.55 - $111.58 $3.86 Million - $6.1 Million	-54,691 Reduced 83.98%	10,432 $848,000
Q2 2022 Aug 11, 2022	BUY	$50.24 - $80.48 $2.85 Million - $4.57 Million	56,795 Added 681.98%	65,123 $4.98 Million
Q1 2022 May 12, 2022	SELL	$57.98 - $93.5 $2,435 - $3,927	-42 Reduced 0.5%	8,328 $688,000
Q4 2021 Feb 11, 2022	BUY	$88.02 - $127.79 $31,951 - $46,387	363 Added 4.53%	8,370 $786,000
Q3 2021 Nov 12, 2021	BUY	$122.75 - $162.68 $123,977 - $164,306	1,010 Added 14.43%	8,007 $1.03 Million
Q2 2021 Aug 12, 2021	BUY	$105.76 - $154.96 $740,002 - $1.08 Million	6,997 New	6,997 $1.08 Million

Others Institutions Holding STAA

# of Institutions

244

Shares Held

44.9M

Call Options Held

230K

Put Options Held

154K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.51B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account